K-STREET TRACKER
FOLLOW THE MONEY INTO THE SWAMP
Every federal lobbying filing tagged with a public-company ticker — who is spending, which firms they hire, and which members trade right around the filing.
Filings tracked
19,882
thru 2026-05-08
Total reported $
$2.7B
disclosed lobbying
Distinct clients
2,220
paying companies
Tickers targeted
1,207
public companies
💸 Top Spending Clients
| # | Client | Filings | Total $ |
|---|---|---|---|
| 1 |  PFIZER INC.PFE | 47 | $46.8M |
| 2 |  GENERAL MOTORS COMPANYGM | 61 | $46.8M |
| 3 |  META PLATFORMS INC. AND VARIOUS SUBSIDIARIESMETA | 12 | $44.9M |
| 4 | VISA INC.V | 45 | $37.7M |
| 5 |  AMAZON.COM SERVICES LLCAMZN | 36 | $32.8M |
| 6 |  LOCKHEED MARTIN CORPORATIONLMT | 73 | $29.0M |
| 7 |  FEDEX CORPORATIONFDX | 69 | $27.8M |
| 8 |  ELI LILLY AND COMPANYLLY | 56 | $27.1M |
| 9 |  ALTRIA CLIENT SERVICES LLCMO | 142 | $25.2M |
| 10 |  AMGEN INCAMGN | 19 | $24.9M |
| 11 |  COMCAST CORPORATIONCMCSV | 179 | $24.7M |
| 12 |  MERCK & CO INCMRK | 14 | $24.0M |
| 13 |  SOUTHERN COMPANYSO | 53 | $23.9M |
| 14 |  GOOGLE CLIENT SERVICES LLCGOOGL | 79 | $22.6M |
| 15 |  APPLE INCAAPL | 9 | $22.1M |
| 16 |  T-MOBILE USA INC.TMUS | 121 | $21.0M |
| 17 |  UNITEDHEALTH GROUP INCUNH | 19 | $20.4M |
| 18 |  VERIZON COMMUNICATIONS INC AND VARIOUS SUBSIDIARIESVZ | 40 | $20.1M |
| 19 |  OCCIDENTAL PETROLEUM CORPORATIONOXY | 30 | $19.7M |
| 20 |  MICROSOFT CORPORATIONMSFT | 103 | $18.8M |
| 21 |  QUALCOMM INCORPORATEDQCOM | 40 | $17.2M |
| 22 |  GENERAL DYNAMICS CORPGD | 11 | $17.0M |
| 23 |  BOEING COMPANYBA | 23 | $16.9M |
| 24 | THE CIGNA GROUP AND SUBSIDIARIES (FORMERLY CIGNA CORPORATION AND SUBSIDIARIES)CI | 13 | $16.9M |
| 25 |  ORACLE CORPORATIONORCL | 58 | $16.7M |
🎯 Top Lobbied Tickers
| # | Ticker | Filings | Total $ |
|---|---|---|---|
| 1 | META Meta Platforms Inc. | 129 | $50.2M |
| 2 | PFE Pfizer Inc. | 87 | $48.6M |
| 3 | GM General Motors Company | 103 | $48.4M |
| 4 | V Visa Inc. | 46 | $37.7M |
| 5 | AMZN Amazon.com Inc. | 80 | $35.3M |
| 6 | LMT Lockheed Martin Corporation | 88 | $29.4M |
| 7 | FDX FedEx Corporation | 82 | $28.3M |
| 8 | LLY Eli Lilly and Company | 83 | $28.1M |
| 9 | AMGN Amgen Inc. | 95 | $28.0M |
| 10 | MRK Merck & Co. Inc. | 92 | $27.5M |
| 11 | AAPL Apple Inc. | 64 | $26.8M |
| 12 | GOOGL Alphabet Inc. Class A | 123 | $26.6M |
| 13 | MO | 164 | $26.2M |
| 14 | SO Southern Company | 108 | $26.1M |
| 15 | UNH UnitedHealth Group Inc. | 67 | $23.9M |
| 16 | VZ Verizon Communications Inc. | 116 | $23.8M |
| 17 | TMUS | 159 | $22.7M |
| 18 |  CHTR | 137 | $22.6M |
| 19 | GD General Dynamics Corporation | 127 | $22.5M |
| 20 |  TAT&T Inc. | 134 | $21.6M |
| 21 | ORCL Oracle Corporation | 132 | $20.6M |
| 22 | CMCSA Comcast Corporation | 141 | $20.4M |
| 23 | CI The Cigna Group | 64 | $19.9M |
| 24 | OXY Occidental Petroleum Corporation | 36 | $19.9M |
| 25 | MSFT Microsoft Corporation | 122 | $19.2M |
🆕 Filtered Filings · HIMS
clear filters| Date | Ticker | Client | Registrant | Amount | Issue |
|---|---|---|---|---|---|
| 2026-04-20 | HIMS | HIMS & HERS HEALTH INC. | HIMS & HERS HEALTH, INC. | $360K | Matters related to compounding, telehealth, and healthcare |
| 2026-04-17 | HIMS | HIMS & HERS HEALTH INC. | CASSIDY & ASSOCIATES, INC. | $60K | Compounding / telehealth / healthcare |
| 2026-04-09 | HIMS | HIMS & HERS HEALTH INC. | KOUNTOUPES DENHAM CARR & REID, LLC | $60K | Issues related to telehealth. Issues related to access to compounded drugs and drug shortages. Issues related to Drug Enforcement Administration Rule (DEA407) concerning Telemedicine Prescribing of Controlled Substances. |
| 2026-01-23 | HIMS | HIMS & HERS HEALTH INC. | HIMS & HERS HEALTH, INC. | $330K | Drug Enforcement Administration Rule (DEA407) concerning Telemedicine Prescribing of Controlled Substances Discussions concerning proposed legislation related to access to compounded drugs and drug shortages H.R.5316 - Drug Shortage Compounding Patient Access Act of 2025 H.R.4605 - End Prescription Drug Ads Now Act H.R.238 - Healthy Technology Act of 2025 S.5040 - Protecting Patients from Deceptive Drug Ads Online Act S.2068 - End Prescription Drug Ads Now Act |
| 2026-01-23 | HIMS | HIMS & HERS HEALTH INC. | HIMS & HERS HEALTH, INC. | $320K | Telehealth Compounded medicines Quality and safety manufacturing |
| 2026-01-23 | HIMS | HIMS & HERS HEALTH INC. | HIMS & HERS HEALTH, INC. | $240K | Drug shortage list FDA transparency |
| 2026-01-20 | HIMS | HIMS & HERS HEALTH INC. (FORMERLY HIMS INC) | CASSIDY & ASSOCIATES, INC. | $60K | Compounding / telehealth / healthcare Compounding / telehealth / healthcare |
| 2026-01-16 | HIMS | HIMS & HERS HEALTH INC. | HIMS & HERS HEALTH, INC. | $280K | Matters related to compounding, telehealth, and healthcare |
| 2026-01-15 | HIMS | HIMS & HERS HEALTH INC. | KOUNTOUPES DENHAM CARR & REID, LLC | $60K | Issues related to telehealth. Issues related to access to compounded drugs and drug shortages. Issues related to Drug Enforcement Administration Rule (DEA407) concerning Telemedicine Prescribing of Controlled Substances. |
| 2025-10-20 | HIMS | HIMS & HERS HEALTH INC. | HIMS & HERS HEALTH, INC. | $320K | Drug Enforcement Administration Rule (DEA407) concerning Telemedicine Prescribing of Controlled Substances Discussions concerning proposed legislation related to access to compounded drugs and drug shortages H.R.5316 - Drug Shortage Compounding Patient Access Act of 2025 H.R.4605 - End Prescription Drug Ads Now Act H.R.238 - Healthy Technology Act of 2025 S.5040 - Protecting Patients from Deceptive Drug Ads Online Act S.2068 - End Prescription Drug Ads Now Act |
| 2025-10-20 | HIMS | HIMS & HERS HEALTH INC. | HIMS & HERS HEALTH, INC. | $310K | Drug Enforcement Administration Rule (DEA407) concerning Telemedicine Prescribing of Controlled Substances Discussions concerning proposed legislation related to access to compounded drugs and drug shortages H.R.5316 - Drug Shortage Compounding Patient Access Act of 2025 H.R.4605 - End Prescription Drug Ads Now Act H.R.238 - Healthy Technology Act of 2025 S.5040 - Protecting Patients from Deceptive Drug Ads Online Act S.2068 - End Prescription Drug Ads Now Act |
| 2025-10-09 | HIMS | HIMS & HERS HEALTH INC. | KOUNTOUPES DENHAM CARR & REID, LLC | $60K | Issues related to telehealth. Issues related to access to compounded drugs and drug shortages. |
| 2025-07-18 | HIMS | HIMS & HERS HEALTH INC. | HIMS & HERS HEALTH, INC. | $310K | Telehealth Compounded medicines Quality and safety manufacturing |
| 2025-07-16 | HIMS | HIMS & HERS HEALTH INC. | KOUNTOUPES DENHAM CARR & REID, LLC | $60K | Issues related to telehealth. Issues related to access to compounded drugs and drug shortages. |
| 2025-04-21 | HIMS | HIMS & HERS HEALTH INC. | HIMS & HERS HEALTH, INC. | $230K | Drug shortage list FDA transparency |
| 2025-04-15 | HIMS | HIMS & HERS HEALTH INC. | KOUNTOUPES DENHAM CARR & REID, LLC | $60K | Issues related to telehealth. Issues related to access to compounded drugs and drug shortages. |
| 2025-03-20 | HIMS | HIMS & HERS HEALTH INC. | HIMS & HERS HEALTH, INC. | $0 | All matters affecting telehealth services All matters affecting telehealth services All matters affecting telehealth services All matters affecting telehealth services All matters affecting telehealth services |
| 2025-02-03 | HIMS | HIMS & HERS HEALTH INC. | KOUNTOUPES DENHAM CARR & REID, LLC | $0 | Issues related to telehealth, compounding and AI. |